Pain
From the Journals
NIH launches HEAL Initiative to combat opioid crisis
HEAL will expand Advancing Clinical Trials in Neonatal Opioid Withdrawal Syndrome (ACT NOW), a pilot study that will assess the prevalence of...
Feature
AMA: Opioid prescriptions down since 2013
Number of providers registered for prescription drug monitoring programs has tripled since 2014.
Conference Coverage
Hip pain predicts OA mortality beyond comorbidities
LIVERPOOL, ENGLAND
Conference Coverage
Prior knee injury osteoarthritis ‘distinct subgroup’
LIVERPOOL, ENGLAND – Individuals who have had a prior knee injury are a distinct subgroup of patients with knee osteoarthritis.
From the Journals
Opioids still overprescribed for postop pain management
Excessive opioid prescriptions can lead to waste and misuse.
News
FDA advisory panelists reject Buvaya for acute pain
HYATTSVILLE, MD. – The 18-1 vote against the buprenorphine sublingual spray for moderate to severe pain is based on concerns about side effects....
Conference Coverage
Disease burden higher in osteoarthritis than rheumatoid arthritis
LIVERPOOL, ENGLAND – Months after diagnosis, osteoarthritis can severely impact patient outcomes to a greater degree than rheumatoid arthritis.
Conference Coverage
VIDEO: Pills alone not the answer for pain management
SANDESTIN, FLA. – A variety of approaches to pain management is absolutely crucial in the area of opioid abuse.
News
FDA approves Aimovig for migraine prevention
Aimovig is the first FDA-approved treatment to prevent migraines by blocking the calcitonin gene–related peptide receptor.
Conference Coverage
Legalization of marijuana debate moving away from medical need
NEW YORK – Initially, the road to legalization was based on claims of medical need, but experts believe that this will no longer be an important...
From the Journals
Fremanezumab may be an effective episodic migraine treatment
The CGRP monoclonal antibody fremanezumab significantly reduced the mean number of migraine days in patients with episodic migraine.